A Beth Israel Deaconess Medical Center study showed dramatic drops in hospital visits for heart attacks and stroke, which likely led to uncounted deaths at home during the COVID crisis. Perhaps more troubling is the potential for long-term damage to decades’ work to catch conditions in their earliest, most treatable stages.
Tags: health-medicine alvin-powell beth-israel-deaconess-medical-center cancer coronavirus covid-19 dhruv-kazi emergency-room harvard-medical-school heart-attack stroke
A new study takes the most comprehensive look to date at the connection between the ancestry and the molecular makeup of cancer.
Tags: health-medicine ancestry basic-research broad-institute cancer human-genome-project nci-cancer-genome-analysis-network tumors
Scientists produce a reference map of human protein interactions, releasing data helpful for understanding diseases including cancer and infectious diseases such as COVID-19.
Tags: science-technology basic-research cancer center-for-cancer-systems-biology covid-19 dana-farber-cancer-institute genes human-genome-project human-reference-interactome infectious-diseases interactome
In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy.
Tags: health-medicine annals-of-oncology basic-research cancer dna grail harvard-medical-school pathfinder
Investigators at Massachusetts General Hospital have modified the gene editing system, making it possible to potentially target any location across the entire human genome.
Tags: science-technology basic-research benjamin-p-kleinstiver blindness cancer cas9 center-for-genomic-medicine crispr gene-editing mgh
Researchers have designed personalized blood biopsies that offer the potential of an early warning signal of breast cancer recurrence.
Tags: science-technology basic-research blood-biopsies breast-cancer broad-institute-of-mit-and-harvard dana-farber-cancer-institute gerstner-center-for-cancer-diagnostics tumor-mutations
Harvard’s Wyss Institute will collaborate with other institutions to form the i3 Center where cancer immunologists and biological engineers will develop new biomaterials-based approaches to enable anti-cancer immune-therapies for therapy-resistant cancers.
Tags: science-technology basic-research engineering harvard-john-a-paulson-school-of-engineering-and-applied-sciences-dana-farber-cancer-institute harvards-department-of-stem-cell-and-regenerative-biology i3-center immune-therapies immuno-engineering-to-improve-immunotherapy-i3-center therapy-resistant-cancers wyss-institute-of-biologically-inspired-engineering-at-harvard-university
A decline in cancer mortality was a prominent feature of recent good news about U.S. life expectancy. The Gazette spoke with the director of the Chan School’s Zhu Family Center for Global Cancer Prevention to understand why.
Tags: health-medicine alvin-powell basic-research breast-cancer cancer cervical-cancer disparities harvard-th-chan-school-of-public-health life-expectancy melanoma national-center-for-health-statistic prostate-cancer timothy-rebbeck zhu-family-center-for-global-cancer-prevention
Professor Emily Balskus and her team have identified an entirely new class of enzymes that degrade chemicals essential for neurological health, but also help digest foods like nuts, berries, and tea, releasing nutrients that may impact human health.
Tags: science-technology bacteria basic-research berries bespoke-diets caitlin-mcdermott-murphy cancer chemistry chemistry-and-chemical-biology chocolate coffee diet dopamine emily-balskus enzymes gut l-dopa microbes microbiology microbiome nutrition nuts parkinsons-disease science vayu-maini-rekdal
Harvard researchers at Dana-Farber Cancer Institute have developed a novel targeted drug that shows promise in advanced kidney cancer by interfering with the abnormal blood vessel formation that fuels tumor growth.
Tags: health-medicine basic-research clear-cell-renal-cell-carcinoma dana-farber-cancer-institute hypoxia-inducible-factor kidney-cancer metastatic-disease mk-6482 nobel-prize phase-iii toni-choueiri tumors william-g-kaelin-jr
Page 1 of 4